- Let's make a deal May 6
There's been a high-stakes reshuffling of the deck in the global pharmaceutical industry, and the latest company to show its hand is Germany's Bayer, which said Tuesday morning that it's purchasing Merck's consumer care unit for $14.2 billion. That means the company that pioneered aspirin — and now also makes Alka-Seltzer, Aleve, and Flintstones vitamins, among other brands — will own Claratin, Afrin, Coppertone, and Dr. Scholl's foot products. But the bigger prize for Bayer, assuming the deal goes through, is that it will be the No. 2 consumer drugmaker in the world, after Johnson & Johnson.- -
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- How the South's ugly racial history is haunting ObamaCare
- 43 TV shows to watch in 2014
- What if Leo Strauss was right?
- Stop making fun of philosophy and read some philosophy
- How to be the most productive person in your office — and still get home by 5:30 p.m.
- Beware of Splenda: The backlash against artificial sugars
- The real story behind Deliver Us From Evil
- 6 things the happiest families all have in common
- The 7 best Halloween-themed editorial cartoons
Subscribe to the Week